ABOUT US
A Trusted Partner for the Biopharmaceutical Industry and Laboratories
Sartorius is a leading international pharmaceutical and laboratory equipment supplier. Our customers work hard to develop and produce drugs that cure, prevent or halt the progress of diseases. To be successful in their endeavors, they rely on partners who understand their current and future challenges. For 150 years, the Sartorius brand has stood for innovative products and solutions that support the work of scientists and engineers worldwide. In doing so, we have increasingly focused on enabling breakthroughs in life science research and biomanufacturing. Sustainability, Openness, Enjoyment - these corporate values are the foundation for innovation and competitive strength at Sartorius. Our values connect us with our customers and business partners just as they do with our investors and society at large - worldwide.
Accelerating Drug Discovery and Simplifying Production
Biopharmaceuticals are produced using living cells in complex and expensive procedures. With our innovative products and services, we enable pharmaceutical researchers and lab personnel to simplify workflows, minimize human errors and speed up their work. We provide solutions that shorten the lengthy and difficult search for active ingredients. For example, new methods for cell analysis help to unlock the great potential of new therapeutic approaches, and software converts data into safe, actionable insights.
Furthermore, manufacturing technologies must also evolve to accelerate the process of taking these innovations from the lab to the clinic to increase patient access. Innovation in upstream & downstream process technologies are needed to improve the efficiency and cost of bio-manufacturing to ultimately make new promising medicines affordable.
Sartorius is part of the solution. Our technologies help simplify and accelerate biopharmaceutical process development through to commercial manufacturing. Designed with a focus on scalability, safety and robustness, we deliver end-to-end solutions and partner with manufacturers to develop optimal process designs specifically fit to their needs. In fact, Sartorius has been pioneering and setting the standards for single-use products that are currently used throughout all biopharmaceutical manufacturing processes. We help our customers to bring medications safely and quickly to the patient.
Corporate Social Responsibility
Sustainability is one of the core values firmly anchored in Sartorius’s corporate culture. It is our primary entrepreneurial responsibility to offer our customers attractive products and solutions. Innovation as well as strategic and operating excellence are the keys to accomplishing this mission. To us, sustainability means that we pursue our corporate objectives from a long-term perspective while clearly addressing social and ecological concerns. We believe that proactive administration of our social and ecological duties is not a means to compensate for our economic actions, but rather is one of the key drivers of our success.
Who we are
The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions complementary technologies. In fiscal 2020, the company earned sales revenue of some 2.34 billion euros. At the end of 2020, nearly 11,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.
CONTACT INFORMATION
Sartorius
565 Johnson Avenue
Bohemia, NY 11716
UNITED STATES
Phone: +1.800.368.7178
Fax: 631-254-4253
FEATURED ARTICLES AND DOWNLOADS
- AAV Empty/Full Ratio Assessment Using The Octet® AAVX Biosensors
- Rapid, Automated, At-Line Adenovirus Quantitation
- Re-Imagine mAb Purification: Discover The Power Of Membranes
- Managing Freeze And Thaw Applications: Single-Use Containers Vs. Bottles
- Evolving Into Biopharma 4.0: A Stepwise Journey Of Digital Transformation
- From CLD To CDMO: Demonstrating A Successful Cell Line Technology Transfer
- Process Intensification And Connected Processing For mAb Manufacturing
- A Checklist For Efficient And Reliable Gene Therapy Manufacturing
- Optimizing Aliquoting For Robust Cell And Gene Therapy Processes
- Best Practices In Aseptic Sampling To Improve Quality In Bioprocessing
- Producing Therapeutic Cardiomyocytes From iPSC Stem Cells
- Why You Need Monoliths To Purify Your Biomolecules
- End-To-End Cold Chain Management: A Next-Generation Approach
- A New Way To Perform mAb Capture
- Re-Imagining Chromatography: Building Efficient Downstream Processes
- Implementing Chromatographic Methods For Evaluating Large-Scale Monolithic Columns For AAV Capsid Separation
- Integrated And Connected Downstream Processing Of mAbs
- Comparability Study Of An Ion Exchange Monolith And Affinity Resin
- Safer And Faster Conjugation And Purification Of ADCs At 1-20 L Scale
- Reagents For Highly Efficient T Cell Manufacturing
- Chromatographic Separation Of Full And Empty AAV8 Capsids
- Intensifying A mAb Polishing Platform
- Optimizing And Intensifying ADC Aggregate Removal With A DoE Approach
- AVV Manufacturing Platform To Produce Safer Vaccines Cheaper
- Demonstrating Effective Scaling Of Rapid Cycling Chromatography
- Overcome The Hidden Complexities Of mRNA Process Development
- Computational Fluid Dynamics For Evaluating Cubical Mixer Performance
- How mRNA Manufacturers Disrupt The Industry
- Defining A Process For Your Unique mRNA
- The Journey To AAV Production In Suspension – Scaling-Up Your Process
- Aseptic Sampling Devices In A Bioburden Reduction Strategy
- Large Volume Tris And DPBS Buffer Preparation
- Developing Biosimilars: Challenges And Solutions
- Expand Your Capabilities And Speed Time-to-Clinic With The Perfect Combination Of Technology And Expertise
- Increased Productivity At The mAb Capture Step
- 5 Reasons To Switch To Multicolumn Chromatography
- Improving Efficiency In Cell Line Development
- The Critical Steps For Protein Therapeutic Potency Assay Development
- How A Single Provider Can Reduce Protein Biologic Development Risk
- A Multi-Scale Approach To CHO Media Benchmarking
- Influence On Measurement Accuracy With Moisture Analyzers
- Are You Compliant When It Comes To Pipetting?
- Sensible Selection And Correct Handling Of Test Weights
- ABCs Of Pipette Tip Purity
- Ultrapure Water For Trace Analysis
- Simplify Upstream Process Intensification From PD To Manufacturing
- Analytical Power Tools Open Upstream Bioprocessing Bottlenecks
- Cell Line Development: Accelerating Antibody Discovery With The Octet® Platform
- Cell Line Development Toolbox For Intensified Bioprocessing
- Cell Line Development Facts & Figures
- Increasing Productivity Of pDNA DSP Using Sample Displacement Chromatography
- Single Cell Passaging With NutriStem® hPSC XF On Laminin-521 Without The Need For ROCK Inhibitor
- A Xeno-Free Culture System For hMSC From Various Sources Suitable For Initial Isolation And Expansion Toward Clinical Applications
- Efficient Transition Of Human Pluripotent Stem Cell Cultures From Essential 8™ Medium Into NutriStem® hPSC XF Medium On Matrigel®
- From Cells To Organs – The Organoid Stepping-Stone
- Efficient Transition Of Human Pluripotent Stem Cell Cultures From StemFlex™ Medium Into NutriStem® hPSC XF Medium On Matrigel®
- Efficient Transition Of Human Pluripotent Stem Cell Cultures From Essential 8™ Medium Into NutriStem® hPSC XF Medium On Vitronectin
- A Unique Defined Pre-Coating - Free Culture Platform For Isolation And Expansion Of hMSC Towards Clinical Applications
- A Guide To Accelerating Cell Line Development For Commercial Production
- Enabling Broader Adoption Of Process Intensification In Biopharma
- Increased Productivity With Concentrated Fed-Batch
- Optimizing Upstream And Downstream Intensification
- Intensified Seed Train Strategy For Faster, Cost-Effective Scale-Up Of Biologics Manufacturing
- Real World Experience: Modular Facilities, Smaller Footprint With Dynamic Perfusion
- Generating A Quality Attribute Profile For Antibody-Based Biosimilars: Assessing Differences In Fc-Associated Effector Functions
- Immuno-Oncology In Vitro Assays
- Capillary Isoelectric Focusing (cIEF) As A Platform Method For The Evaluation Of Monoclonal Antibody Charge Variants
- Development And Qualification Of A Complex Potency ELISA
- Commercial Vaccine Manufacturing - How To Prepare For Rapid Set-Up
- Multi-Column Chromatography Process Modelling For Process Performance Prediction
- QRM For Filter Integrity Testing: Complying With EMA's Future Annex 1
- Accelerate Process Intensification For Viral Vaccine Manufacturing
- Can mRNA Disrupt The Biopharma Industry?
- Integrated Tools For Upstream Process Intensification: Part II
- Integrated Tools For Upstream Process Intensification: Part I
- Key Concepts Driving The Future Of Single-Use In Biopharma Production
- Biosafety Considerations For Single-Use Bioreactors
- Accelerate Process Development With High-Throughput, Single-Use, Fully Automated Bioreactors
- Accelerating Biopharmaceutical Development From DNA To Drug
- Single-Use Process Platforms Help Biomanufacturers Reduce Costs
- A Look Into The Future Of Bioprocessing
- Managing Frozen Transport Logistics In The Biopharma
- Integrated Platform For Intelligent Upstream Process Intensification
- The Value Of Spent Media Analytics For Optimizing Cell Culture Performance
- Achieving Protein A Resin Reduction With Process Transfer